Indonesia First Country to Approve Emergency Use of Novavax COVID-19 Vaccine

Novavax in Rockville, Md., in a file photograph. Paul J. Richards/AFP via Getty Images

Indonesian health officials have approved the COVID-19 vaccine produced by U.S.-based biotechnology company Novavax Inc., making the Asian nation the first country worldwide to authorize the new shot.

“The first authorization of Novavax’s COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia,” said Stanley Erck, Novavax’s chief executive.